Impact of Secukinumab on Clinical and Patient Reported Outcomes in Patients With Psoriasis
Clinical trial NCT05513014 · COMPLETED
Trial details
- NCT number
- NCT05513014
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-03-21
- Primary completion
- 2021-08-31
- Enrollment
- 1518
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.